Adalimumab/infliximabDevelopment of drug resistance: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1893卷 / 1期

关键词：

D O I：

10.1007/s40278-022-09801-0

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：18 / 18

相关论文

共 50 条

[41] LevofloxacinAcquired drug resistance: case report
Reactions Weekly, 2023, 1964 (1) : 252 - 252
[42] BevacizumabAcquired drug resistance: case report
Reactions Weekly, 2016, 1602 (1) : 54 - 54
[43] LamivudineDevelopment of drug resistance: case report
Reactions Weekly, 2019, 1758 (1) : 212 - 212
[44] NivolumabAcquired drug resistance: case report
Reactions Weekly, 2019, 1757 (1) : 232 - 232
[45] CeftazidimeAcquired drug resistance: case report
Reactions Weekly, 2025, 2042 (1) : 111 - 111
[46] BedaquilineDevelopment of drug resistance: case report
Reactions Weekly, 2023, 1984 (1) : 109 - 109
[47] ErlotinibAcquired drug resistance: case report
Reactions Weekly, 2025, 2049 (1) : 150 - 150
[48] KanamycinAcquired drug resistance: case report
Reactions Weekly, 2019, 1765 (1) : 209 - 209
[49] GefitinibAcquired drug resistance: case report
Reactions Weekly, 2020, 1833 (1) : 185 - 185
[50] PralsetinibAcquired drug resistance: case report
Reactions Weekly, 2022, 1927 (1) : 451 - 451

← 1 2 3 4 5 →